These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29747811)

  • 21. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.
    Ngamukote S; Yanagisawa M; Ariga T; Ando S; Yu RK
    J Neurochem; 2007 Dec; 103(6):2327-41. PubMed ID: 17883393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.
    Sandhoff K
    Biochimie; 2016 Nov; 130():146-151. PubMed ID: 27157270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. My journey into the world of sphingolipids and sphingolipidoses.
    Sandhoff K
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(10):554-82. PubMed ID: 23229750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganglioside glycosyltransferases and newly synthesized gangliosides are excluded from detergent-insoluble complexes of Golgi membranes.
    Crespo PM; Zurita AR; Giraudo CG; Maccioni HJ; Daniotti JL
    Biochem J; 2004 Feb; 377(Pt 3):561-8. PubMed ID: 14565845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
    Sandhoff K; Kolter T; Van Echten-Deckert G
    Ann N Y Acad Sci; 1998 Jun; 845():139-51. PubMed ID: 9668348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
    Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
    Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-system disorders of glycosphingolipid and ganglioside metabolism.
    Xu YH; Barnes S; Sun Y; Grabowski GA
    J Lipid Res; 2010 Jul; 51(7):1643-75. PubMed ID: 20211931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.
    Kolter T; Sandhoff K
    Annu Rev Cell Dev Biol; 2005; 21():81-103. PubMed ID: 16212488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycosphingolipid structural analysis and glycosphingolipidomics.
    Levery SB
    Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation.
    Schulze H; Kolter T; Sandhoff K
    Biochim Biophys Acta; 2009 Apr; 1793(4):674-83. PubMed ID: 19014978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of glycosphingolipid metabolism in the developing brain.
    Yu RK; Nakatani Y; Yanagisawa M
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S440-5. PubMed ID: 18845618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gangliosides and cell surface ganglioside glycohydrolases in the nervous system.
    Aureli M; Samarani M; Murdica V; Mauri L; Loberto N; Bassi R; Prinetti A; Sonnino S
    Adv Neurobiol; 2014; 9():223-44. PubMed ID: 25151381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases.
    Pagano RE
    Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):885-91. PubMed ID: 12803922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganglioside biosynthesis in developing brains and apoptotic cancer cells: X. regulation of glyco-genes involved in GD3 and Sialyl-Lex/a syntheses.
    Basu S; Ma R; Moskal JR; Basu M
    Neurochem Res; 2012 Jun; 37(6):1245-55. PubMed ID: 22488330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemistry of glycosphingolipid degradation.
    Sandhoff K; Kolter T
    Clin Chim Acta; 1997 Oct; 266(1):51-61. PubMed ID: 9435988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary accumulation of gangliosides in lysosomal storage disorders.
    Walkley SU
    Semin Cell Dev Biol; 2004 Aug; 15(4):433-44. PubMed ID: 15207833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Golgi localization of glycosyltransferases involved in ganglioside biosynthesis.
    van Echten-Deckert G; Gurgui M
    Curr Drug Targets; 2008 Apr; 9(4):282-91. PubMed ID: 18393822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycan Chains of Gangliosides: Functional Ligands for Tissue Lectins (Siglecs/Galectins).
    Ledeen RW; Kopitz J; Abad-Rodríguez J; Gabius HJ
    Prog Mol Biol Transl Sci; 2018; 156():289-324. PubMed ID: 29747818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topology of glycosphingolipid degradation.
    Sandhoff K; Kolter T
    Trends Cell Biol; 1996 Mar; 6(3):98-103. PubMed ID: 15157485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex gangliosides are apically sorted in polarized MDCK cells and internalized by clathrin-independent endocytosis.
    Crespo PM; von Muhlinen N; Iglesias-Bartolomé R; Daniotti JL
    FEBS J; 2008 Dec; 275(23):6043-56. PubMed ID: 19021775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.